Does Rallies track congressional trades in BAX?

Yes. Rallies tracks politician and congressional stock disclosures for BAX, including reported purchases, sales, dates, owners, and trade amounts when available.

Is BAX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BAX. It does not provide personalized investment advice.

BAX (Baxter) Stock Analysis - Politician Trades

Baxter (BAX) is a publicly traded Healthcare sector company. As of May 21, 2026, BAX trades at $18.76 with a market cap of $9.19B and a P/E ratio of -9.93. BAX moved +2.56% today. Year to date, BAX is -5.63%; over the trailing twelve months it is -40.34%. Its 52-week range spans $15.73 to $39.57. Analyst consensus is neutral with an average price target of $20.38. Rallies surfaces BAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded BAX stock?

Recent politician trading activity in BAX includes disclosures from Michael McCaul, Michael McCaul, Lisa McClain, Lisa McClain, and Lisa McClain. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

BAX Key Metrics

Key financial metrics for BAX
Metric	Value
Price	$18.76
Market Cap	$9.19B
P/E Ratio	-9.93
EPS	$-1.87
Dividend Yield	0.01%
52-Week High	$39.57
52-Week Low	$15.73
Volume	5.39M
Avg Volume	0
Revenue (TTM)	$11.24B
Net Income	$-957.00M
Gross Margin	30.05%

Congressional Trades in BAX

Michael McCaul purchase BAX on Mar 23, 2026 (amount: $50.00K) for Spouse.
Michael McCaul purchase BAX on Jan 13, 2026 (amount: $100.00K) for Spouse.
Lisa McClain sale BAX on Oct 31, 2025 (amount: $15.00K) for Spouse.
Lisa McClain sale BAX on Oct 30, 2025 (amount: $15.00K) for Spouse.
Lisa McClain purchase BAX on Sep 25, 2025 (amount: $15.00K) for Spouse.

Latest BAX News

Baxter drops as Q1 2026 earnings release hits tape on May 13 — May 13, 2026
Baxter stock climbs as Q1 beat and reaffirmed 2026 outlook drive follow-through buying — May 6, 2026
Baxter stock slides as Q1 loss, pump remediation and cost headwinds weigh — May 4, 2026
Baxter International Q1 Revenue Rises 2.9% to $2.70B, EPS Beats — Apr 30, 2026
Baxter jumps after Q1 2026 earnings beat as sales growth surprises — Apr 30, 2026

BAX Analyst Consensus

9 analysts cover BAX: 0 strong buy, 2 buy, 6 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $20.38.

Common questions about BAX

Which politicians traded BAX stock?: Recent politician trading activity in BAX includes disclosures from Michael McCaul, Michael McCaul, Lisa McClain, Lisa McClain, and Lisa McClain. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in BAX?: Yes. Rallies tracks politician and congressional stock disclosures for BAX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is BAX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BAX. It does not provide personalized investment advice.